Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason J Yi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Biological Chemistry|June 1, 2017
The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasomeJason J Yi, Smita R Paranjape, Matthew P Walker, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
A membrane-permeable small molecule biosensor accesses intractable cells and animals without genetic manipulationGabriel Kreider, Christopher J MacNevin, Pothiappan Vairaprakash, et al.
Cell Reports|June 30, 2023
Autism-linked UBE3A gain-of-function mutation causes interneuron and behavioral phenotypes when inherited maternally or paternally in miceLei Xing, Jeremy M Simon, Travis S Ptacek, et al.
Nature Communications|November 24, 2021
Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysisKellan P Weston, Xiaoyi Gao, Jinghan Zhao, et al.
Scientific Reports|March 18, 2025
The gain-of-function UBE3A<sup>Q588E</sup> variant causes Angelman-like neurodevelopmental phenotypes in miceKellan P Weston, Anna M Gunelson, Susan E Maloney, et al.
Nature Aging|March 30, 2023
Human striatal glia differentially contribute to AD- and PD-specific neurodegenerationJinbin Xu, Huifangjie L Farsad, Yiran Hou, et al.
Journal of Neurodevelopmental Disorders|March 7, 2026
Crossing the finish line towards a disease-modifying treatment for Angelman syndromeMatthew C Judson, Luis Pereira de Almeida, Rebecca D Burdine, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Biological Chemistry|June 1, 2017
The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasomeJason J Yi, Smita R Paranjape, Matthew P Walker, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
A membrane-permeable small molecule biosensor accesses intractable cells and animals without genetic manipulationGabriel Kreider, Christopher J MacNevin, Pothiappan Vairaprakash, et al.
Cell Reports|June 30, 2023
Autism-linked UBE3A gain-of-function mutation causes interneuron and behavioral phenotypes when inherited maternally or paternally in miceLei Xing, Jeremy M Simon, Travis S Ptacek, et al.
Nature Communications|November 24, 2021
Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysisKellan P Weston, Xiaoyi Gao, Jinghan Zhao, et al.
Scientific Reports|March 18, 2025
The gain-of-function UBE3A<sup>Q588E</sup> variant causes Angelman-like neurodevelopmental phenotypes in miceKellan P Weston, Anna M Gunelson, Susan E Maloney, et al.
Nature Aging|March 30, 2023
Human striatal glia differentially contribute to AD- and PD-specific neurodegenerationJinbin Xu, Huifangjie L Farsad, Yiran Hou, et al.
Journal of Neurodevelopmental Disorders|March 7, 2026
Crossing the finish line towards a disease-modifying treatment for Angelman syndromeMatthew C Judson, Luis Pereira de Almeida, Rebecca D Burdine, et al.
Pageof 2